Company intelligence / Profile preview

Suzhou Hengrui Hongyuan Medical

Suzhou, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Suzhou Hengrui Hongyuan Medical Technology is a specialized medical device company focused on the development and commercialization of innovative interventional products for structural heart disease. As a subsidiary of Jiangsu Hengrui Pharmaceuticals, the company leverages extensive R&D resources to advance its pipeline of transcatheter valve repair and replacement systems. Its primary focus includes the development of transcatheter aortic valve replacement (TAVR) and mitral valve repair technologies. The company aims to provide high-quality, domestic alternatives for complex cardiovascular interventions in the Chinese market.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Suzhou Hengrui Hongyuan Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Suzhou Hengrui Hongyuan Medical.

Explore the full profile